Catalent revenue increased from $2.5 billion in 2019 to $3.1 billion in 2020, a (22.9%) increase.

Annual Revenue ($)

Catalent revenue was $3.09 b in FY, 2020 which is a (22.9%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$2.46 b$2.52 b$3.09 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021
Revenue$551.8 m$623 m$617.5 m$664.7 m$721.4 m$760.6 m$845.7 m$910.8 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Catalent revenue breakdown by business segment: 32.9% from Biologics, 21.8% from Oral and Specialty Delivery, 11.1% from Clinical Supply Services and 34.2% from Softgel and Oral Technologies

Catalent revenue breakdown by geographic segment: 57.4% from United States, 30.8% from Europe and 11.8% from Other

FY, 2020FY, 2019FY, 2018
Biologics and Specialty Drug Delivery$742.1 m$601.9 m
Oral Drug Delivery$619.9 m$573.9 m
Clinical Supply Services$345 m$321.4 m$430.4 m
Softgel Technologies$872.1 m$917.3 m
Biologics$1.02 b
Oral and Specialty Delivery$675.9 m
Softgel and Oral Technologies$1.06 b
FY, 2020FY, 2019FY, 2018
Europe976.1 m842.1 m897.8 m
International Other433.8 m415.3 m
United States1.82 b1.32 b1.22 b
Other$375.8 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu